コロナウイルス検査キットのヨーロッパ市場2021年-2025年

◆英語タイトル:Coronavirus Test Kits Market in Europe 2021-2025
◆商品コード:IRTNTR43247
◆発行会社(リサーチ会社):Technavio
◆発行日:2021年4月16日
◆ページ数:約120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:ヨーロッパ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

テクナビオ社はヨーロッパのコロナウイルス検査キット市場規模が、2021年~2025年まで年平均28%減少し、46.1億ドルに達すると予測しています。本調査レポートでは、ヨーロッパのコロナウイルス検査キット市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、エンドユーザー別分析、顧客状況、地域別状況、企業状況、企業分析など、以下の構成でまとめております。
【レポートの概要】

Coronavirus Test Kits Market in Europe 2021-2025Technavio has been monitoring the coronavirus test kits market in Europe and it is poised to decline by $ 4.61 billion during 2021-2025, progressing at a CAGR of almost (28)% during the forecast period. Our report on the coronavirus test kits market in Europe provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing government funding and the rising focus on preventing the spread of the COVID-19 pandemic. In addition, increasing government funding is anticipated to boost the growth of the market as well.

The coronavirus test kits market in Europe analysis includes the end-user segment and geographic landscape.

Technavio’s coronavirus test kits market in Europe is segmented as below:
By End-user
• Government
• Non-government

By Geographical Landscape
• UK
• Russian Federation
• Italy
• Germany
• Rest of Europe

This study identifies the increasing number of strategic alliances as one of the prime reasons driving the coronavirus test kits market in Europe growth during the next few years.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the coronavirus test kits market in Europe covers the following areas:
• Coronavirus test kits market sizing in Europe
• Coronavirus test kits market forecast in Europe
• Coronavirus test kits market industry analysis in Europe

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading coronavirus test kits market vendors in Europe that include 3D Biomedicine Science and Technology Co. Ltd., Abbott Laboratories, BGI Genomics Co. Ltd., bioMerieux SA, Co-Diagnostics Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., Guangzhou Wondfo Biotech Co. Ltd., QIAGEN NV, and Thermo Fisher Scientific Inc. Also, the coronavirus test kits market analysis report in Europe includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/corona-virus-test-kits-market-in-europe-industry-analysis
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

【レポートの目次】

• Executive Summary
o Market overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2020
o Market outlook: Forecast for 2020 – 2025
• Five Forces Analysis
o Five Forces Analysis
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by End-user
o Market segments
o Comparison by End user
o Government – Market size and forecast 2020-2025
o Non government – Market size and forecast 2020-2025
o Market opportunity by End user
• Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o UK – Market size and forecast 2020-2025
o Russian Federation – Market size and forecast 2020-2025
o Italy – Market size and forecast 2020-2025
o Germany – Market size and forecast 2020-2025
o Rest of Europe – Market size and forecast 2020-2025
o Market opportunity by geography
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o 3D Biomedicine Science and Technology Co. Ltd.
o Abbott Laboratories
o BGI Genomics Co. Ltd.
o bioMerieux SA
o Co-Diagnostics Inc.
o Danaher Corp.
o F. Hoffmann-La Roche Ltd.
o Guangzhou Wondfo Biotech Co. Ltd.
o QIAGEN NV
o Thermo Fisher Scientific Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Parent market
• 8: Market characteristics
• 9: Offerings of vendors included in the market definition
• 10: Market segments
• 11: Global – Market size and forecast 2020 – 2025 ($ million)
• 12: Global market: Year-over-year growth 2020 – 2025 (%)
• 13: Five forces analysis 2020 & 2025
• 14: Bargaining power of buyers
• 15: Bargaining power of suppliers
• 16: Threat of new entrants
• 17: Threat of substitutes
• 18: Threat of rivalry
• 19: Market condition – Five forces 2020
• 20: End user – Market share 2020-2025 (%)
• 21: Comparison by End user
• 22: Government – Market size and forecast 2020-2025 ($ million)
• 23: Government – Year-over-year growth 2020-2025 (%)
• 24: Non government – Market size and forecast 2020-2025 ($ million)
• 25: Non government – Year-over-year growth 2020-2025 (%)
• 26: Market opportunity by End user
• 27: Customer landscape
• 28: Market share by geography 2020-2025 (%)
• 29: Geographic comparison
• 30: UK – Market size and forecast 2020-2025 ($ million)
• 31: UK – Year-over-year growth 2020-2025 (%)
• 32: Russian Federation – Market size and forecast 2020-2025 ($ million)
• 33: Russian Federation – Year-over-year growth 2020-2025 (%)
• 34: Italy – Market size and forecast 2020-2025 ($ million)
• 35: Italy – Year-over-year growth 2020-2025 (%)
• 36: Germany – Market size and forecast 2020-2025 ($ million)
• 37: Germany – Year-over-year growth 2020-2025 (%)
• 38: Rest of Europe – Market size and forecast 2020-2025 ($ million)
• 39: Rest of Europe – Year-over-year growth 2020-2025 (%)
• 40: Key leading countries
• 41: Market opportunity by geography ($ million)
• 42: Impact of drivers and challenges
• 43: Vendor landscape
• 44: Landscape disruption
• 45: Industry risks
• 46: Vendors covered
• 47: Market positioning of vendors
• 48: 3D Biomedicine Science and Technology Co. Ltd. – Overview
• 49: 3D Biomedicine Science and Technology Co. Ltd. – Product and service
• 50: 3D Biomedicine Science and Technology Co. Ltd. – Key offerings
• 51: 3D Biomedicine Science and Technology Co. Ltd. – Key customers
• 52: 3D Biomedicine Science and Technology Co. Ltd. – Segment focus
• 53: Abbott Laboratories – Overview
• 54: Abbott Laboratories – Business segments
• 55: Abbott Laboratories – Key offerings
• 56: Abbott Laboratories – Key customers
• 57: Abbott Laboratories – Segment focus
• 58: BGI Genomics Co. Ltd. – Overview
• 59: BGI Genomics Co. Ltd. – Product and service
• 60: BGI Genomics Co. Ltd. – Key offerings
• 61: BGI Genomics Co. Ltd. – Key customers
• 62: BGI Genomics Co. Ltd. – Segment focus
• 63: bioMerieux SA – Overview
• 64: bioMerieux SA – Business segments
• 65: bioMerieux SA – Key offerings
• 66: bioMerieux SA – Key customers
• 67: bioMerieux SA – Segment focus
• 68: Co-Diagnostics Inc. – Overview
• 69: Co-Diagnostics Inc. – Business segments
• 70: Co-Diagnostics Inc. – Key offerings
• 71: Co-Diagnostics Inc. – Key customers
• 72: Co-Diagnostics Inc. – Segment focus
• 73: Danaher Corp. – Overview
• 74: Danaher Corp. – Business segments
• 75: Danaher Corp. – Key offerings
• 76: Danaher Corp. – Key customers
• 77: Danaher Corp. – Segment focus
• 78: F. Hoffmann-La Roche Ltd. – Overview
• 79: F. Hoffmann-La Roche Ltd. – Business segments
• 80: F. Hoffmann-La Roche Ltd. – Key offerings
• 81: F. Hoffmann-La Roche Ltd. – Key customers
• 82: F. Hoffmann-La Roche Ltd. – Segment focus
• 83: Guangzhou Wondfo Biotech Co. Ltd. – Overview
• 84: Guangzhou Wondfo Biotech Co. Ltd. – Product and service
• 85: Guangzhou Wondfo Biotech Co. Ltd. – Key offerings
• 86: Guangzhou Wondfo Biotech Co. Ltd. – Key customers
• 87: Guangzhou Wondfo Biotech Co. Ltd. – Segment focus
• 88: QIAGEN NV – Overview
• 89: QIAGEN NV – Business segments
• 90: QIAGEN NV – Key offerings
• 91: QIAGEN NV – Key customers
• 92: QIAGEN NV – Segment focus
• 93: Thermo Fisher Scientific Inc. – Overview
• 94: Thermo Fisher Scientific Inc. – Business segments
• 95: Thermo Fisher Scientific Inc. – Key offerings
• 96: Thermo Fisher Scientific Inc. – Key customers
• 97: Thermo Fisher Scientific Inc. – Segment focus
• 98: Currency conversion rates for US$
• 99: Research Methodology
• 100: Validation techniques employed for market sizing
• 101: Information sources
• 102: List of abbreviations



【掲載企業】

3D Biomedicine Science and Technology Co. Ltd., Abbott Laboratories, BGI Genomics Co. Ltd., bioMerieux SA, Co-Diagnostics Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., Guangzhou Wondfo Biotech Co. Ltd., QIAGEN NV, Thermo Fisher Scientific Inc.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[コロナウイルス検査キットのヨーロッパ市場2021年-2025年]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆